As Europe’s medical cannabis market matures, a new category of operator is beginning to emerge. One focused not simply on
UK clinic Releaf expands into Germany, leveraging its digital health ecosystem to capture market share in Europe’s fast-growing medical cannabis sector.
Since the UK legalisation of CBPMs in 2018, the sector has faced slow adoption due to ineffective patient outreach, inconsistent supply chains and variable quality control from other providers.
We won’t spam you
